Cargando…
Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy
Red blood cells (RBCs) have recently emerged as promosing candidates for cancer treatment in terms of relieving tumor hypoxia and inducing oxidative damage against cancer cells, but they are still far from satisfactory due to their limited oxygen transport and reactive oxygen species generation rate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817004/ https://www.ncbi.nlm.nih.gov/pubmed/35122163 http://dx.doi.org/10.1007/s40820-022-00801-z |
_version_ | 1784645542996869120 |
---|---|
author | Li, Jiong Wang, Sijia Lin, Xinyi Cao, Yanbing Cai, Zhixiong Wang, Jing Zhang, Zhenxi Liu, Xiaolong Wu, Ming Yao, Cuiping |
author_facet | Li, Jiong Wang, Sijia Lin, Xinyi Cao, Yanbing Cai, Zhixiong Wang, Jing Zhang, Zhenxi Liu, Xiaolong Wu, Ming Yao, Cuiping |
author_sort | Li, Jiong |
collection | PubMed |
description | Red blood cells (RBCs) have recently emerged as promosing candidates for cancer treatment in terms of relieving tumor hypoxia and inducing oxidative damage against cancer cells, but they are still far from satisfactory due to their limited oxygen transport and reactive oxygen species generation rate in tumor tissue. Herein, artificial RBCs (designated FTP@RBCM) with radical storm production ability were developed for oncotherapy through multidimensional reactivity pathways of Fe-protoporphyrin-based hybrid metal–organic frameworks (FTPs, as the core), including photodynamic/chemodynamic-like, catalase-like and glutathione peroxidase-like activities. Meanwhile, owing to the advantages of long circulation abilities of RBCs provided by their cell membranes (RBCMs), FTP with a surface coated with RBCMs (FTP@RBCM) could enormously accumulate at tumor site to achieve remarkably enhanced therapeutic efficiency. Intriguingly, this ROS-mediated dynamic therapy was demonstrated to induce acute local inflammation and high immunogenic cancer death, which evoked a systemic antitumor immune response when combined with the newly identified T cell immunoglobulin and mucin-containing molecule 3 (Tim-3) checkpoint blockade, leading to not only effective elimination of primary tumors but also an abscopal effect of growth suppression of distant tumors. Therefore, such RBC-mimic nanocatalysts with multidimensional catalytic capacities might provide a promising new insight into synergistic cancer treatment. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40820-022-00801-z. |
format | Online Article Text |
id | pubmed-8817004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Nature Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-88170042022-02-16 Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy Li, Jiong Wang, Sijia Lin, Xinyi Cao, Yanbing Cai, Zhixiong Wang, Jing Zhang, Zhenxi Liu, Xiaolong Wu, Ming Yao, Cuiping Nanomicro Lett Article Red blood cells (RBCs) have recently emerged as promosing candidates for cancer treatment in terms of relieving tumor hypoxia and inducing oxidative damage against cancer cells, but they are still far from satisfactory due to their limited oxygen transport and reactive oxygen species generation rate in tumor tissue. Herein, artificial RBCs (designated FTP@RBCM) with radical storm production ability were developed for oncotherapy through multidimensional reactivity pathways of Fe-protoporphyrin-based hybrid metal–organic frameworks (FTPs, as the core), including photodynamic/chemodynamic-like, catalase-like and glutathione peroxidase-like activities. Meanwhile, owing to the advantages of long circulation abilities of RBCs provided by their cell membranes (RBCMs), FTP with a surface coated with RBCMs (FTP@RBCM) could enormously accumulate at tumor site to achieve remarkably enhanced therapeutic efficiency. Intriguingly, this ROS-mediated dynamic therapy was demonstrated to induce acute local inflammation and high immunogenic cancer death, which evoked a systemic antitumor immune response when combined with the newly identified T cell immunoglobulin and mucin-containing molecule 3 (Tim-3) checkpoint blockade, leading to not only effective elimination of primary tumors but also an abscopal effect of growth suppression of distant tumors. Therefore, such RBC-mimic nanocatalysts with multidimensional catalytic capacities might provide a promising new insight into synergistic cancer treatment. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40820-022-00801-z. Springer Nature Singapore 2022-02-05 /pmc/articles/PMC8817004/ /pubmed/35122163 http://dx.doi.org/10.1007/s40820-022-00801-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Li, Jiong Wang, Sijia Lin, Xinyi Cao, Yanbing Cai, Zhixiong Wang, Jing Zhang, Zhenxi Liu, Xiaolong Wu, Ming Yao, Cuiping Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title | Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title_full | Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title_fullStr | Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title_full_unstemmed | Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title_short | Red Blood Cell-Mimic Nanocatalyst Triggering Radical Storm to Augment Cancer Immunotherapy |
title_sort | red blood cell-mimic nanocatalyst triggering radical storm to augment cancer immunotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817004/ https://www.ncbi.nlm.nih.gov/pubmed/35122163 http://dx.doi.org/10.1007/s40820-022-00801-z |
work_keys_str_mv | AT lijiong redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT wangsijia redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT linxinyi redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT caoyanbing redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT caizhixiong redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT wangjing redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT zhangzhenxi redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT liuxiaolong redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT wuming redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy AT yaocuiping redbloodcellmimicnanocatalysttriggeringradicalstormtoaugmentcancerimmunotherapy |